Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial.

Literature DB >> 35086895

Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial.

Phillip H Kuo¹, Taylor Benson², Richard Messmann², Michael Groaning³.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2022 PMID： 35086895 DOI： 10.2967/jnumed.121.263638

Source DB: PubMed Journal: J Nucl Med ISSN： 0161-5505 Impact factor: 10.057

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. Baseline Imaging Derived Predictive Factors of Response Following [¹⁷⁷Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis.

Authors: Esmée C A van der Sar; Adinda J S Kühr; Sander C Ebbers; Andrew M Henderson; Bart de Keizer; Marnix G E H Lam; Arthur J A T Braat
Journal: Biomedicines Date: 2022-07-01

1 in total

Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial.

1. Baseline Imaging Derived Predictive Factors of Response Following [177Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis.

1. Baseline Imaging Derived Predictive Factors of Response Following [¹⁷⁷Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis.